Real-world data from Fall Clinical 2026 reveal widespread treatment dissatisfaction, anxiety, and steroid hesitancy among ...
Michelle Min, MD, MS, reviewed best practices for managing cutaneous lupus and discussed emerging therapies practitioners ...
Post hoc ICONIC phase 3 data show GLP-1 medications do not affect the efficacy, safety, or pharmacokinetics of icotrokinra in ...
Dr Hamzavi discussed how to navigate conversations with patients with HS regarding common misconceptions, expectations with ...
Panelists highlight major 2026 approvals, novel oral therapies, expanded pediatric indications, and new severity definitions shaping clinical practice. Recent advances have changed clinical practice ...
Investigators studied treatment patterns among patients with generalized pustular psoriasis (GPP) to determine the use of GPP-specific therapies. Corticosteroids remained the primary therapy overall, ...
Phase 3b TOGETHER trial results presented at FC26 show concomitant ixekizumab and tirzepatide significantly improve joint and skin outcomes while driving meaningful weight loss in patients with ...
Dermatology Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results